Catalyst Wire Dossier Catalyst Wire Dossier

IPX159

· Impax Laboratories, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPX159, covering 2017-02-01 to 2017-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) [Phase 2]

See pricing